NR3C1 and acute lymphoblastic leukemia: Sensitivity to GCs correlated very well with the glucocorticoid receptor (NR3C1) protein abundance (R ≥ 0.74, P ≤ 1.7e-8) (Fig. 4c), consistent with associations between favorable patient response to GCs and basal expression levels of NR3C1 in ALL and myelomas56,57.